The Evidence Trust Crisis
Why more data, faster analytics, and easier access are accelerating output while eroding trust.
Download our eBook: The Evidence Trust Crisis
As real-world data (RWD), analytics platforms, automation, and AI have made healthcare research faster and more accessible, the volume of evidence being produced has increased dramatically. However, the ability to generate answers has begun to outpace the ability to trust them. The result is a growing “Evidence Trust Crisis” in which studies that appear credible may fail under scientific, regulatory, or peer scrutiny.
High-quality data does not automatically produce high-quality evidence. Defensible evidence requires well-defined research questions, fit-for-purpose data, rigorous methodology, transparency, reproducibility, and expert scientific judgment. A key distinction is that data quality and evidence quality are not the same thing. Data may be structurally sound, complete, and clinically plausible, yet still lead to flawed conclusions if researchers ask the wrong question, use inappropriate methodologies, misinterpret limitations, or fail to understand what the data does and does not capture.
In this eBook, we identify several contributors to the trust gap:
- Easier access to large datasets and analytic tools.
- Increased pressure for faster results and publication.
- Misalignment between research questions, methods, and available data.
- Overreliance on automation without adequate scientific oversight.
- Insufficient transparency and reproducibility in study design and execution.
The Bottom Line: The healthcare industry does not need more evidence—it needs more trustworthy evidence. As regulators, payers, and researchers place increasing scrutiny on how evidence is generated, organizations must move beyond simply accessing data and focus on applying rigorous scientific discipline, transparent methodologies, and fit-for-purpose data evaluation. Trustworthy evidence is ultimately the product of both quality data and quality science. The future of real-world evidence will be defined not by who has the most data, but by who can consistently generate transparent, reproducible, and scientifically
"*" indicates required fields
"*" indicates required fields
Find out more
Looking to evaluate your clinical trial readiness? Take our quiz to discover your real-world data impact and optimize your strategy.
Our Consulting Services provide scientific expertise for regulatory engagements, study design, and more.
In our webinar, discover how RWD study design can strengthen causal inference and support fit-for-purpose data decisions.